Metabolic syndrome in postmenopausal breast cancer survivors

To assess the occurrence of metabolic syndrome (MetS) in postmenopausal breast cancer survivors. A total of 158 breast cancer survivors were included in this cross-sectional study. Eligibility criteria were: women with amenorrhea >12 months and age ≥45 years, treated for breast cancer and no meta...

Full description

Saved in:
Bibliographic Details
Published in:Revista Brasileira de ginecologia e obstetrícia 2012-12, Vol.34 (12), p.555-562
Main Authors: Nahas, Eliana Aguiar Petri, de Almeida, Bruno da Rosa, Buttros, Daniel de Araújo Brito, Véspoli, Heloísa De Luca, Uemura, Gilberto, Nahas-Neto, Jorge
Format: Article
Language:Portuguese
Subjects:
Breast Neoplasms - therapy
Cross-Sectional Studies
Female
Humans
Metabolic Syndrome - epidemiology
Middle Aged
Postmenopause
Risk Factors
Survivors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To assess the occurrence of metabolic syndrome (MetS) in postmenopausal breast cancer survivors. A total of 158 breast cancer survivors were included in this cross-sectional study. Eligibility criteria were: women with amenorrhea >12 months and age ≥45 years, treated for breast cancer and no metastasis for at least five years. Clinical history and anthropometric indicator data (body mass index (BMI), and waist circumference, (WC) were collected. Biochemical parameters, including total cholesterol, HDL, LDL, triglycerides (TG), glucose and C-reactive protein (CRP), were measured. MetS was diagnosed as the presence of at least three of the following diagnostic criteria: WC>88 cm, blood pressure≥130/85 mmHg, triglycerides≥150 mg/dl, HDL
ISSN:1806-9339
DOI:10.1590/S0100-72032012001200005